- Home
- ISTR vs STTK Comparison
ISTR vs STTK Comparison
Compare ISTR & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- STTK
- Stock Information
- Founded
- ISTR 2006
- STTK 2016
- Country
- ISTR United States
- STTK United States
- Employees
- ISTR N/A
- STTK N/A
- Industry
- ISTR Major Banks
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- STTK Health Care
- Exchange
- ISTR Nasdaq
- STTK Nasdaq
- Market Cap
- ISTR 189.6M
- STTK 37.6M
- IPO Year
- ISTR 2014
- STTK 2020
- Fundamental
- Price
- ISTR $21.87
- STTK $0.83
- Analyst Decision
- ISTR Buy
- STTK Hold
- Analyst Count
- ISTR 1
- STTK 4
- Target Price
- ISTR $27.00
- STTK $3.00
- AVG Volume (30 Days)
- ISTR 46.0K
- STTK 423.3K
- Earning Date
- ISTR 07-21-2025
- STTK 07-31-2025
- Dividend Yield
- ISTR 1.89%
- STTK N/A
- EPS Growth
- ISTR 22.25
- STTK N/A
- EPS
- ISTR 2.19
- STTK N/A
- Revenue
- ISTR $88,885,000.00
- STTK $4,606,000.00
- Revenue This Year
- ISTR $2.04
- STTK N/A
- Revenue Next Year
- ISTR $9.79
- STTK N/A
- P/E Ratio
- ISTR $10.12
- STTK N/A
- Revenue Growth
- ISTR 6.35
- STTK 69.65
- 52 Week Low
- ISTR $15.39
- STTK $0.69
- 52 Week High
- ISTR $24.81
- STTK $4.99
- Technical
- Relative Strength Index (RSI)
- ISTR 70.31
- STTK 38.86
- Support Level
- ISTR $21.97
- STTK $0.75
- Resistance Level
- ISTR $22.46
- STTK $0.85
- Average True Range (ATR)
- ISTR 0.68
- STTK 0.09
- MACD
- ISTR 0.32
- STTK -0.01
- Stochastic Oscillator
- ISTR 90.89
- STTK 9.59
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.